AAOS Official Statements
Advisory Statements
- Communicating Adverse Outcomes
- Recommendations for the Use of Intravenous Antibiotic Prophylaxis in Primary Total Joint Arthroplasty
- Prevention of Medication Errors
- Wrong-Site Surgery
- Use of Prophylactic Antibiotics/Vancomycin-Resistant Bacteria
- Use of Musculoskeletal Tissue Allografts
- Use of Thermal Modalities (Lasers and Radiofrequency Devices) in Orthopaedic Surgery
- Preventing the Transmission of Bloodborne Pathogens
- Implant Device Recalls
- Cell and Tissue-Engineered Products
- Antibiotic Prophylaxis for Urological Patients with Total Joint Replacements
- Antibiotic Prophylaxis for Dental Patients with Total Joint Replacements
Position Statement
Member Services
Orthopaedic Residents
International Membership
Leadership Information
Practice Management
- Overview & Useful Links
- Private Practice Operations
- Academic Practice Operations
- News Dispatch
- CPT/ICD-9 Coding Counsel
- Compliance
- Advice Center
- Practice Transitions